Remdesivir

Red

Brand Name(s):Veklury

Indication:Coronavirus disease 2019 (COVID-19)

Rationale:1,5

Considered:Sep-20

Review Date:Sep-21

Comments:
Remdesivir is licensed for the treatment of coronavirus disease 2019 (COVID-19) in adults and adolescents (aged 12 years and older with body weight at least 40 kg) with pneumonia requiring supplemental oxygen.